603858 Shandong Buchang Pharmaceuticals
- 16.96
- +0.12+0.71%
Shandong Buchang Pharmaceuticals News
Announcement of the progress of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares reaching 3% and the progress of the repurchase
Announcement of the progress of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Announcement of Implementation of Equity Distribution of Shandong Buchang Pharmaceuticals Co., Ltd. for the Year 2023.
Announcement on adjusting the total amount of cash dividends for profit distribution in 2023 by Shandong Buchang Pharmaceuticals Co., Ltd.
Progress Announcement of Shandong Buchang Pharmaceuticals Co.'s Repurchase of Shares through Centralized Competitive Trading
Progress Announcement of Shandong Buchang Pharmaceuticals Co.'s Repurchase of Shares through Centralized Competitive Trading
Shandong Buchang Pharmaceuticals Co., Ltd. announces the progress of repurchasing company's shares reaching 2%.
Announcement of Shandong Buchang Pharmaceuticals Co., Ltd. on Adjusting the Plan for Repurchasing Shares through Centralized Bidding Trading
Shandong Buchang Pharmaceuticals Co., Ltd.'s repurchase report (revised draft) on repurchasing shares through centralized auction trading
Progress Announcement of Shandong Buchang Pharmaceuticals Co.'s Repurchase of Shares through Centralized Competitive Trading
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the controlling shareholder's share pledge
Announcement of the progress of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Announcement of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of the company's shares reaching 1% and the progress of the repurchase
Shandong Buchang Pharmaceutical Co., Ltd. plans to conduct an impairment test on the goodwill formed from the acquisition of shares in Jilin Tiancheng Pharmaceutical Co., Ltd. Asset Group Recoverable Amount Asset Assessment Report
Shandong Buchang Pharmaceutical Co., Ltd. plans to conduct an impairment test on the goodwill formed from the acquisition of shares in Tonghua Guhong Pharmaceutical Co., Ltd. Asset Group Recoverable Amount Asset Assessment Report
Shandong Buchang Pharmaceutical Co., Ltd. 2023 Profit Distribution Plan Announcement
Announcement of the progress of Shandong Buchang Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Shandong Buchang Pharmaceutical Co., Ltd. Simplified Equity Change Report
Shandong Buchang Pharmaceutical Co., Ltd.'s indicative announcement on changes in shareholders' equity with a shareholders' shareholding ratio reaching 5%
Analysis
Price Target
No Data
No Data